Drug Information
| Drug General Information | |||||
|---|---|---|---|---|---|
| Drug ID |
DXS6NM
|
||||
| Drug Name |
N-((S)-1-((4S,7R)-7-methyl-3-oxo-1-(pyridin-2-ylsulfonyl)azepan-4-ylamino)-3-(1-methylcyclohexyl)-1-oxopropan-2-yl)morpholine-4-carboxamide
|
||||
| Synonyms |
CHEMBL1807701
|
||||
| Indication | Discovery agent | Investigative | [1587926] | ||
| Formula |
C27H41N5O6S
|
||||
| Canonical SMILES |
C[C@@H]1CC[C@H](NC(=O)[C@H](CC2(C)CCCCC2)NC(=O)N3CCOCC3)C(=O)CN1S(=O)(=O)c4ccccn4
|
||||
| InChI |
InChI=1S/C27H41N5O6S/c1-20-9-10-21(23(33)19-32(20)39(36,37)24-8-4-7-13-28-24)29-25(34)22(18-27(2)11-5-3-6-12-27)30-26(35)31-14-16-38-17-15-31/h4,7-8,13,20-22H,3,5-6,9-12,14-19H2,1-2H3,(H,29,34)(H,30,35)/t20-,21+,22+/m1/s1
|
||||
| InChIKey |
WYBFWCUCYMPPNV-FSSWDIPSSA-N
|
||||
| Target and Pathway | |||||
| Target(s) | Cathepsin K | Target Info | [1587926] | ||
| Cathepsin L | Target Info | [1587926] | |||
| Reactome | Collagen degradation | ||||
| Degradation of the extracellular matrix | |||||
| Activation of Matrix Metalloproteinases | |||||
| Trafficking and processing of endosomal TLR | |||||
| MHC class II antigen presentationR-HSA-1236977:Endosomal/Vacuolar pathway | |||||
| Assembly of collagen fibrils and other multimeric structures | |||||
| MHC class II antigen presentation | |||||
| References | |||||
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.